The fact that the majority of patients present either CYP2D6*4 or CYP2D6*10 genotypes indicates that individuals with PM genotypes of CYP2D6 are more prone to develop HNSCC [135]. The gene discussed is CYP2D6; the disease is head and neck squamous cell carcinoma.